| Faculty Home Biophysics Home UM Home | ||||||||
Raymond C. Trievel |
||||||||
Assistant Professor of Biological Chemistry |
||||||||
Ph.D., University of Pennsylvania |
||||||||
| Dept: Department of Biological Chemistry | ||||||||
| Office Address: 4412 Medical Science Building I | ||||||||
| Phone: 734-647-0889 | ||||||||
|
Email: rtrievel@umich.edu |
||||||||
| Post-translational
modifications of proteins play pivotal roles in governing a myriad of
biological functions within the cell. Gene expression, the cell cycle,
intracellular signaling cascades, cytoskeletal organization, and
numerous metabolic pathways are just a few examples of cellular
functions that are controlled by covalent modifications. Our laboratory
is interested in understanding how protein modifications within the
nucleus impact transcription and other genomic processes. Histones, the
major scaffolding proteins that organize genomic DNA in chromatin, are
enriched in modifications such as acetylation, methylation,
phosphorylation and ubiquitination. Transcription factors and other
components of the transcriptional machinery are subject to similar
types of covalent modifications in vivo. These modifications
collectively act as molecular switches that can either activate or
repress gene expression, depending on the pattern of modifications
established within a given gene locus. Aberrant histone modifications
have been directly linked to carcinogenesis, underscoring the
fundamental importance of these pathways in governing faithful gene
expression. Our laboratory is currently investigating histone lysine methyltransferases (HKMTs), a group of enzymes that epigenetically regulate transcription, heterochromatin structure, DNA damage checkpoints, development, differentiation, and the cell cycle. Using structural and biochemical techniques, we have characterized the molecular basis of substrate recognition for several representative HKMTs in order to elucidate the mechanisms by which they catalyze site-specific lysine methylation in histones and other nuclear proteins. A thorough understanding of these specificities is critical to human health because aberrant HKMT activity has been clinically documented in a broad spectrum of cancers, including prostate, breast, lung, hepatic, and colorectal cancers. We envision that our research will enable us to develop HKMT inhibitors as novel chemotherapeutic agents and will also impact gene therapy and stem cell research due to the central importance of gene regulation to these fields. |
||||||||
|
|
||||||||
|
|
||||||||
Representative Publications |
||||||||
Couture, J.F., Hauk, G., Thompson, M.J., Blackburn, G.M., and Trievel, R.C. (2006) Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases. J Biol Chem., in press. |
||||||||
|
|
||||||||
| Top | ||||||||
|
||||||||